Disease
4 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
This is a Phase 2 platform trial registration with no results reported; it describes a planned interventional study in early-stage disease with a surrogate endpoint (tau PET), appropriate for preliminary classification.
This is a study registration for a Phase 2 platform trial that is actively recruiting with no results posted; it describes planned design and endpoints only.
AUG 20, 2026 · PHASE 1 TRIAL
ClinicalTrials.gov
Phase 1 trial of a novel tau vaccine in preclinical AD; no results reported in this registry record, and the primary focus is safety and tolerability rather than clinical efficacy.
This is a registry record for an ongoing observational study with no results reported; it describes planned enrollment and biomarker measurement in a natural history cohort without intervention allocation or outcome data.